3MS PHARMA LIMITED

🌿Early-stageactive
15236137 · ltd · incorporated 2023-10-25
Investment thesis
Growth-phase business — story-led; valuation sensitive to momentum.
Why interesting: Trading is scaling; acquirers paying for trajectory get disproportionate leverage.
Why risky: Price often leads fundamentals; dependency on founder often high.
🔒Estimated value
Upgrade to see
Turnover
year to Oct 2024
Net worth
£260
book net assets
Opportunity
70/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Dispensing chemist in specialised stores
Sector: Wholesale & retail
Investor take
Pursue
Strong opportunity: asset-holding vehicle with strong profile and acceptable with review structure.

Opportunity 70/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (58/100).

Data confidence

Overall: medium (71/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
1 year of iXBRL accounts extracted (no YoY comparison) + narrative notes parsed
50
Lenders & charges
Confirmed no charges registered
85
Directors & officers
1 officers (1 active, 1 linked, 1 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
4 connected companies via shared directors
57
Filing history
5 filings
60
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
70/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
60
Adequate — check latest filings for context.
Acquirability
50
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · accounting standard not declared
Positive net assets
Net assets £260

Key financials

1 year extracted from filed iXBRL accounts
Cash
Net Worth
£260
Current Assets
£100
Current Liabilities

Financials

Extracted from Companies House accounts · accounting standard unknown
Metric2024-10-31
Total assets£260
Current assets£100
Net assets£260

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
0
filings
Counts from Companies House filing history.
Corporate timeline (4 events)Click to expand
  1. 2025-07-22
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  2. 2023-10-25
    🏢
    Company incorporated
    As 3MS PHARMA LIMITED
  3. 2023-10-25
    BOPPANA, Murali Krishna appointed
    director
  4. 2023-10-25
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

80/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.
  • +Young company: Only 2.6 years old — management layer unlikely to be developed.

Succession & seller-readiness

45/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Mr Murali Krishna Boppana
Individual · British · DOB 06/1978 · age 48
75100%
75–100%75-100% shares · 75-100% voting25/10/2023

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Retail · MK postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
123FLOOR LIMITED
07385620 · est 2010 · no financials extracted
15y
1744 LTD
13531385 · est 2021 · no financials extracted
4y
234NG LTD
13103521 · est 2020 · no financials extracted
5y
3TRIPLE TTT LTD
14130416 · est 2022 · no financials extracted
3y
4LINES LTD
16105338 · est 2024 · no financials extracted
1y
80S CASUAL CLASSICS LTD
06922118 · est 2009 · no financials extracted
16y
99 DIGITAL LTD
13150023 · est 2021 · no financials extracted
5y
A B CABLES LIMITED
04640903 · est 2003 · no financials extracted
23y
A BUNCH OF OLD BOOKS LTD
16532471 · est 2025 · no financials extracted
A&C PARTNERS LTD
14281033 · est 2022 · no financials extracted
3y
A1M LIMITED
16481121 · est 2025 · no financials extracted
A2Z TRENDZ LTD
16567094 · est 2025 · no financials extracted
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2023-10-25
Jurisdictionengland-wales
Primary SIC47730 — Dispensing chemist in specialised stores

Registered office

3 Chianina Close
Whitehouse
Milton Keynes
MK8 1DJ
England

Filing status

Accounts
Next due: 2026-07-31
Last made up to: 2024-10-31
Confirmation statement
Next due: 2026-11-10
Last: 2025-10-27

Officers (1 active · 0 resigned)

BOPPANA, Murali Krishna
director · ~48y · appointed 2023-10-25
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (5 total)

confirmation-statement-with-updates
confirmation-statement · CS01
2025-10-27
accounts-with-accounts-type-micro-entity
accounts · AA
2025-07-22
confirmation-statement-with-updates
confirmation-statement · CS01
2024-11-01
confirmation-statement-with-updates
confirmation-statement · CS01
2023-10-27
incorporation-company
incorporation · NEWINC
2023-10-25